These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9121610)

  • 1. Effects of chronic treatment with haloperidol on [3H]PK 11195 binding in the rat brain and peripheral tissues.
    Kurumaji A; Kaneko K; Toru M
    Neuropharmacology; 1996; 35(8):1075-9. PubMed ID: 9121610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labelling of "peripheral-type" benzodiazepine binding sites in the rat brain by using [3H]PK 11195, an isoquinoline carboxamide derivative: kinetic studies and autoradiographic localization.
    Benavides J; Quarteronet D; Imbault F; Malgouris C; Uzan A; Renault C; Dubroeucq MC; Gueremy C; Le Fur G
    J Neurochem; 1983 Dec; 41(6):1744-50. PubMed ID: 6315880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated haloperidol treatment decreases sigma(1) receptor binding but does not affect its mRNA levels in the guinea pig or rat brain.
    Inoue A; Sugita S; Shoji H; Ichimoto H; Hide I; Nakata Y
    Eur J Pharmacol; 2000 Aug; 401(3):307-16. PubMed ID: 10936488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with haloperidol and diazepam alters GABA(A) receptor density in the rat brain.
    McLeod MC; Sundram S; Dean B
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):560-7. PubMed ID: 18045761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in [3H]-PK 11195 and [3H]-8-OH-DPAT binding following forebrain ischaemia in the gerbil.
    Kenny BA; MacKinnon AC; Spedding M; Brown CM
    Br J Pharmacol; 1993 Jun; 109(2):437-42. PubMed ID: 8395288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic phenobarbital administration affects GABA and benzodiazepine receptors in the brain and periphery.
    Weizman A; Fares F; Pick CG; Yanai J; Gavish M
    Eur J Pharmacol; 1989 Oct; 169(2-3):235-40. PubMed ID: 2553448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic injection of kainic acid: gliosis in olfactory and limbic brain regions quantified with [3H]PK 11195 binding autoradiography.
    Altar CA; Baudry M
    Exp Neurol; 1990 Sep; 109(3):333-41. PubMed ID: 2209775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clozapine metabolites and chronic clozapine treatment on rat brain GABAA receptors.
    Wong G; Kuoppamäki M; Hietala J; Lüddens H; Syvälahti E; Korpi ER
    Eur J Pharmacol; 1996 Oct; 314(3):319-23. PubMed ID: 8957253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype specificity of gamma-aminobutyric acid type A receptor antagonism by clozapine.
    Korpi ER; Wong G; Lüddens H
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):365-73. PubMed ID: 8532064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the binding of sigma opioids and phencyclidine, and the interaction with antipsychotic drugs in rat brain membranes.
    Downes CP; Lewis PE; Stone MA
    Br J Pharmacol; 1986 May; 88(1):231-7. PubMed ID: 2871882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol treatment differentially regulates [3H]DTG and [3H](+)-3-PPP labeled sigma binding sites.
    Bailey MA; Karbon EW
    Eur J Pharmacol; 1993 Aug; 240(2-3):243-50. PubMed ID: 7902283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat.
    Rägo L; Saano V; Auvinen T; Adojaan A; Holma R; Airaksinen MM
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):432-6. PubMed ID: 1331816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics.
    Tarazi FI; Florijn WJ; Creese I
    Psychopharmacology (Berl); 1996 Dec; 128(4):371-9. PubMed ID: 8986008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding characteristics of [3H]DAA1106, a novel and selective ligand for peripheral benzodiazepine receptors.
    Chaki S; Funakoshi T; Yoshikawa R; Okuyama S; Okubo T; Nakazato A; Nagamine M; Tomisawa K
    Eur J Pharmacol; 1999 Apr; 371(2-3):197-204. PubMed ID: 10357257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic haloperidol administration on GABA receptor binding.
    Huffman RD; Ticku MK
    Pharmacol Biochem Behav; 1983 Aug; 19(2):199-204. PubMed ID: 6314387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone.
    Leysen JE; Janssen PM; Gommeren W; Wynants J; Pauwels PJ; Janssen PA
    Mol Pharmacol; 1992 Mar; 41(3):494-508. PubMed ID: 1372084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram and diethyldithiocarbamate are competitive inhibitors at the peripheral benzodiazepine receptor.
    Katz Y; Weizman R; Weizman A; Gavish M
    J Pharmacol Exp Ther; 1992 Jul; 262(1):394-7. PubMed ID: 1320691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.
    Benavides J; Guilloux F; Rufat P; Uzan A; Renault C; Dubroeucq MC; Gueremy C; Le Fur G
    Eur J Pharmacol; 1984 Mar; 99(1):1-7. PubMed ID: 6723786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative autoradiographic studies of the effects of bilateral olfactory bulbectomy in the rat brain: central- and peripheral-type benzodiazepine receptors.
    Beauchemin V; Lavoie N; Dennis T
    Neuroscience; 1994 Feb; 58(3):527-37. PubMed ID: 8170536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subchronic treatment of rats with remoxipride fails to modify sigma binding sites in the brain.
    Ericson H; Ross SB
    Eur J Pharmacol; 1992 Jun; 226(2):157-61. PubMed ID: 1353452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.